Biolase Technology, Inc.

Device firm provides share repurchase update

Published in Health Business Week, October 15th, 2004

Biolase Technology, Inc., (BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on improving dental procedures, provided an update on its share repurchase program originally announced on July 19, 2004, and subsequently expanded to a total of 2.0 million shares on August 9, 2004.

As of August 31, 2004, the company had repurchased 1,477,000 shares. Timing of repurchases and exact number of shares of common stock to be purchased in the future will depend upon prevailing market conditions and other factors.

Federico Pignatelli, Biolase's chairman commented, "We believe that our shares continue to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2004-10-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry